187 related articles for article (PubMed ID: 9394911)
21. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
22. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
[TBL] [Abstract][Full Text] [Related]
23. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
24. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
Escudero Barrilero A
Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
[No Abstract] [Full Text] [Related]
26. [BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder].
Sánchez-Martín FM; Palou Redorta J; Regalado Pareja R; Rubio Briones J; Villavicencio Mavric H; Vicente Rodríguez J
Arch Esp Urol; 1999 Sep; 52(7):749-58. PubMed ID: 10540765
[TBL] [Abstract][Full Text] [Related]
27. Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
Tsai HK; Katz MS; Coen JJ; Zietman AL; Kaufman DS; Shipley WU
Urology; 2006 Dec; 68(6):1188-92. PubMed ID: 17141846
[TBL] [Abstract][Full Text] [Related]
28. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
[TBL] [Abstract][Full Text] [Related]
29. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
van der Heijden AG; Kiemeney LA; Gofrit ON; Nativ O; Sidi A; Leib Z; Colombo R; Naspro R; Pavone M; Baniel J; Hasner F; Witjes JA
Eur Urol; 2004 Jul; 46(1):65-71; discussion 71-2. PubMed ID: 15183549
[TBL] [Abstract][Full Text] [Related]
30. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
[TBL] [Abstract][Full Text] [Related]
31. Bladder cancer.
Ozen H
Curr Opin Oncol; 1998 May; 10(3):273-8. PubMed ID: 9619365
[TBL] [Abstract][Full Text] [Related]
32. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
33. The management of superficial bladder cancer.
Dalbagni G
Nat Clin Pract Urol; 2007 May; 4(5):254-60. PubMed ID: 17483810
[TBL] [Abstract][Full Text] [Related]
34. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
[TBL] [Abstract][Full Text] [Related]
35. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
36. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy and chemotherapy in infiltrating bladder tumors].
Durdux C; Housset M
Rev Prat; 1997 Feb; 47(4):392-5. PubMed ID: 9114525
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome of high-grade non-muscle-invasive bladder cancer: a long-term single center experience.
Iida S; Kondo T; Kobayashi H; Hashimoto Y; Goya N; Tanabe K
Int J Urol; 2009 Mar; 16(3):287-92. PubMed ID: 19207115
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]